Pfizer (NY:PFE)

28.21 -0.30 (-1.07%)

Delayed Quote Updated: 12:16 PM EDT, Oct 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

99 100 Next >

Viatris (NASDAQ:VTRS) Posts Better-Than-Expected Sales In Q4 CY2025

February 26, 2026

Medication company Viatris (NASDAQ:VTRS) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 5% year on year to $3.7 billion. The company’s full-year revenue guidance of...

Via StockStory

NVAX Stock Rises Overnight Ahead Of Q4 Print With Pfizer Tailwinds — Analyst Warns Of 20% Crash ↗

February 26, 2026

Koyfin analysts expect revenue to grow nearly 28% from the last quarter and forecast losses to narrow significantly.

Via Stocktwits

Gilead’s Twice-Yearly HIV Breakthrough: A Paradigm Shift in Global Prevention and Market Dominance

February 25, 2026

The global landscape of HIV prevention and treatment has reached a historic turning point following the clinical triumph and subsequent commercial launch of Gilead Sciences’ (Nasdaq: GILD) lenacapavir,...

Via MarketMinute

Topics Intellectual Property

Eli Lilly Just Took 2 Major Steps Forward in the Billion-Dollar Obesity Drug Market. Here's What You Need to Know. ↗

February 25, 2026

Eli Lilly has seen revenue and earnings soar in recent years.

Via The Motley Fool

Pfizer's Braftovi Regimen Wins Complete FDA Nod For Colorectal Cancer Treatment ↗

February 25, 2026

Pfizer stock rises after FDA fully approves Braftovi combo for metastatic colorectal cancer with BRAF V600E mutation.

Via Benzinga

Novo Nordisk's 40% Fall May Be Creating A Deep-Value Moment ↗

February 25, 2026

Novo Nordisk now trades at just 10.6x earnings after a 58% crash, far below Eli Lilly, Vertex, and Pfizer — signaling a valuation reset.

Via Benzinga

Pfizer Stock: Is PFE Underperforming the Healthcare Sector?

February 25, 2026

Due to Pfizer’s underperformance relative to the healthcare sector over the past year, Wall Street analysts remain cautious about the stock’s prospects

Via Barchart.com

Topics ETFs Intellectual Property World Trade

U.S. FDA Grants Full Approval to Pfizer’s BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

February 24, 2026

From Pfizer Inc.

Via Business Wire

Novavax Q4 Earnings Preview: Wall Street Expects Wider Losses Amid Diversification Efforts ↗

February 24, 2026

According to data from Fiscal AI, Novavax is expected to report a quarterly loss per share of $0.55, higher than the loss of $0.52 reported in the corresponding quarter of 2024.

Via Stocktwits

Topics Artificial Intelligence Earnings

This Dividend Giant Pfizer Could Turn a Boring Healthcare Allocation Into Serious Income ↗

February 24, 2026

Pfizer says it is standing behind its dividend, which makes the stock's 6.4% yield quite attractive.

Via The Motley Fool

Topics Intellectual Property

TinyGemsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Appoints Dr. Freda Lewis-Hall to Board and Scientific Advisory Committee Chair

February 24, 2026

Via Investor Brand Network

Next-Generation Psychiatric Therapies Target Massive $40B+ Market Opportunity

February 24, 2026

EQNX::TICKER_START (NASDAQ:HELP),(CBOE:HELP),(NYSE:TAK),(NASDAQ:CMPS),(NYSE:PFE),(NYSE:BMY) EQNX::TICKER_END

Via FinancialNewsMedia

Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee

February 24, 2026

In this role, Dr. Lewis-Hall will guide clinical development strategy, regulatory engagement, and translational rigor across Helus’ novel serotonergic agonist (“NSA”) portfolio This news release...

Via FinancialNewsMedia

Nasdaq, S&P 500 Futures Steady After AI Fears Roil Tech: Why IBM, NVDA, NFLX, HIMS, PFE Are On Traders' Radar Today ↗

February 24, 2026

Data from Stocktwits indicated retail sentiment on SPY and QQQ remained ‘bearish’ on Stocktwits.

Via Stocktwits

Topics Artificial Intelligence ETFs Government

Novo Nordisk Shares Tumble 15.1% After CagriSema Fails to Topple Eli Lilly in Head-to-Head Trial

February 23, 2026

The undisputed reign of Novo Nordisk in the weight-loss drug sector faced its most severe challenge to date on February 23, 2026, as the company’s US-traded shares (NYSE: NVO) plummeted 15.1% in a...

Via MarketMinute

Kenvue Defies Market Headwinds with Q4 Earnings Beat as Kimberly-Clark Merger Looms

February 23, 2026

In a pivotal moment for the consumer health landscape, Kenvue (NYSE: KVUE) has reported a robust set of fourth-quarter results for 2025, signaling a successful turnaround and strategic resilience just...

Via MarketMinute

Topics Earnings Economy World Trade

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

February 23, 2026

From Pfizer Inc.

Via Business Wire

February 22, 2026

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...

Via StockStory

Celcuity Stock Soars 700% in a Year as One Investor's $17 Million Buy Helps Create Top Two Position ↗

February 22, 2026

Celcuity develops targeted cancer therapies and diagnostic platforms, with a focus on advancing precision medicine in oncology.

Via The Motley Fool

My 5 Favorite Dividend Stocks to Buy Right Now ↗

February 22, 2026

There are several solid prospects to choose from right now, but there's a reason I can't get these particular names out of my head.

Via The Motley Fool

Massive News: Pfizer's 6% Dividend Could Be Safer Than You Think ↗

February 21, 2026

Is Pfizer's 6% yield a rare opportunity hiding in plain sight, or are investors overlooking a major risk that could reshape its future?

Via The Motley Fool

Is Pfizer Stock an Underrated Healthcare Investment Play? ↗

February 20, 2026

Pfizer is playing catch-up in the GLP-1 drug space, but the drugmaker has a long history of success.

Via The Motley Fool

Topics Intellectual Property

Explore the S&P500 index on Friday and find out which stocks are the most active in today's session. ↗

February 20, 2026

Via Chartmill

Is Pfizer Stock the Only Big Pharma Name I'd Buy and Hold Through Any Market Crash? ↗

February 20, 2026

New products are already generating growth.

Via The Motley Fool

Topics Intellectual Property

Warning: This Skyrocketing Stock Has a Hidden Risk ↗

February 19, 2026

Eli Lilly is leading the pack in the GLP-1 weight-loss drug market, but this good news won't last forever.

Via The Motley Fool

Topics Intellectual Property

Pfizer’s BRAFTOVI BREAKWATER Trial Delivers Landmark Survival Gains in Colorectal Cancer

February 19, 2026

NEW YORK — Pfizer Inc. (NYSE: PFE) has announced breakthrough results from its Phase 3 BREAKWATER clinical trial, demonstrating that its BRAFTOVI (encorafenib) regimen significantly improves both...

Via MarketMinute

Top High-Yield Stocks to Double Up on Right Now ↗

February 19, 2026

If you are looking for high-yield stocks, these two turnaround stories offer yield and green shoots, suggesting better times are ahead.

Via The Motley Fool

Nasdaq, S&P 500 Futures Edge Higher, Trump Speech In Focus: Why WMT, META, IBRX, MSFT, EBAY Are On Traders' Radar Today ↗

February 19, 2026

Data from Stocktwits indicated retail sentiment towards SPY and QQQ cooled to neutral.

Via Stocktwits

Topics ETFs Economy Government

2 Large-Cap Stocks on Our Watchlist and 1 We Brush Off

February 18, 2026

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an...

Via StockStory

MoonLake Stock Soars As Biotech Fund Reloads, Takeover Chatter Ignites ↗

February 17, 2026

Optimism also grew around FDA momentum for its palmoplantar pustulosis drug ahead of MoonLake’s Feb. 23 investor day.

Via Stocktwits

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.